Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction

M F Melhem1, A I Meisler, R Saito

  • 1Department of Pathology, University of Pittsburgh School of Medicine, PA.

Blood
|October 1, 1993
PubMed

Insights

Inflammatory malignant fibrous histiocytomas (IMFH) produce cytokines that cause leukemoid reactions and paraneoplastic symptoms. These cytokine expressions explain tumor aggressiveness and patient symptoms.

Area of Science:

  • Oncology
  • Immunology
  • Pathology

Background:

  • Inflammatory malignant fibrous histiocytomas (IMFH) are rare tumors often linked to leukocytosis.
  • Leukemoid reactions in IMFH cases have been rarely attributed to tumor-secreted, unidentified hematopoietic factors.

Observation:

  • Immunohistochemical analysis of IMFH malignant cells revealed diverse cytokine immunoreactivity.
  • Comparison with non-inflammatory malignant fibrous histiocytomas highlighted specific cytokine profiles in IMFH.

Findings:

  • IMFH tumors expressed stem cell factor (SCF), granulocyte colony-stimulating factor (G-CSF), and various interleukins (IL-2, IL-4, IL-5) and interferons (IFN-alpha).
  • Additionally, IMFH showed elevated levels of IL-6, IL-7, IL-8, IFN-gamma, and keratinocyte growth factor, not found in non-inflammatory types.
  • Elevated serum SCF, G-CSF, IL-6, and tumor necrosis factor were detected in patients, correlating with bone marrow hypercellularity and paraneoplastic symptoms.

Implications:

  • Cytokine dysregulation in IMFH malignant cells likely drives local inflammation, fibrosis, and tumor aggression.
  • Specific cytokine profiles may explain distinct leukemoid reactions (eosinophilic vs. granulocytic) observed in IMFH patients.
  • Tumor-derived cytokines may contribute to paraneoplastic syndromes, including fever, malaise, and weight loss.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...